ProPhase Labs’ Resolution for 2025: Nail Down a ‘Liquidity Event’
The company has lost nearly $36 million since 2023, but its CEO is aggressively pursuing new revenue options
Laboratory Industry Report
Keeps You Up-to-Date on Lab Business and Competitive Strategy, Market Trends and Opportunities, and M&A and Investment Activity in Today’s Diagnostic Lab Industry
Subscribe today for access to
Articles and Reports
Out with the Old: The 2024 Clinical Lab Experience
What challenges and opportunities affected the experience of medical lab professionals in 2024—and what might the new year bring?
FDA Watch: How Could the Change in US Government Affect IVDs and Labs?
Experts say new leadership could impact the cost and availability of IVDs as well as patients’ ability to afford lab testing
Abbott Asks Court to Pull the Plug on Alere Merger
From - Laboratory Industry Report
Abbott officially wants out of its $5.8 billion merger with Alere. Last week, the Illinois-based diagnostics giant asked a Delaware Chancery Court to…
3 Things You Need to Know about the Lab Fee Schedule
From - Laboratory Industry Report
The Centers for Medicare and Medicaid Services (CMS) issued the final 2017 Clinical Laboratory Fee Schedule (CLFS) on Nov. 21. Here is a look at…
OPPS 2017: The 4 Things Labs Need to Know
From - Laboratory Industry Report
The Centers for Medicare and Medicaid Services (CMS) recently published final rules on reimbursement under the…
Quest Diagnostics Unveils a Pair of Personalized Medicine Blockbusters
...
Already a member? Log in here
Is the Alere Dispute Hurting Abbott’s Strategic Position?
...
Already a member? Log in here
FDA Puts LDT Guidance on Ice
...
Already a member? Log in here
So, Now What? How a Trump Presidency Will Impact Labs & the ACA
...
Already a member? Log in here